The Cost of Stopping (Futility) Rules Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients in Brazil

被引：0
|
作者：
Morais, A. D. [1 ]
Pereira, M. L. [1 ]
机构：
[1] Janssen Cilag Farmaceut, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.137
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A345 / A345
页数：1
相关论文
共 50 条
  • [21] Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
    Bruno, Annalisa
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [22] A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C
    Jacobson, I. M.
    Pawlotsky, J. -M.
    Afdhal, N. H.
    Dusheiko, G. M.
    Forns, X.
    Jensen, D. M.
    Poordad, F.
    Schulz, J.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 1 - 26
  • [23] UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients
    Ramachandran, P.
    Fraser, A.
    Agarwal, K.
    Austin, A.
    Brown, A.
    Foster, G. R.
    Fox, R.
    Hayes, P. C.
    Leen, C.
    Mills, P. R.
    Mutimer, D. J.
    Ryder, S. D.
    Dillon, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (06) : 647 - 662
  • [24] THE COMPARATIVE EFFICACY OF TELAPREVIR VERSUS BOCEPREVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS
    Diels, J.
    Cure, S.
    Gavart, S.
    VALUE IN HEALTH, 2011, 14 (07) : A266 - A266
  • [25] Telaprevir for the treatment of genotype 1 chronic hepatitis C virus
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (02) : 159 - 159
  • [26] Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
    Yang, Chi-Chieh
    Tsai, Wei-Lun
    Su, Wei-Wen
    Huang, Chung-Feng
    Cheng, Pin-Nan
    Lo, Ching-Chu
    Tseng, Kuo-Chih
    Mo, Lein-Ray
    Wang, Chun-Hsiang
    Hsu, Shih-Jer
    Lai, Hsueh-Chou
    Su, Chien-Wei
    Liu, Chun-Jen
    Peng, Cheng-Yuan
    Yu, Ming-Lung
    PLOS ONE, 2015, 10 (09):
  • [27] FUTILITY TESTING AT TREATMENT WEEK 8 IN PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE 1 INFECTION RECEIVING BOCEPREVIR: A POST HOC ANALYSIS
    Jacobson, I. M.
    Silva, M.
    Bruno, S.
    Calleja, J. -L.
    Bacon, B.
    Esteban, R.
    Poordad, F.
    Bronowicki, J. -P.
    Sulkowski, M. S.
    Vierling, J. M.
    Flamm, S.
    Colvard, L.
    Thompson, S.
    Koury, K.
    Helmond, F. A.
    Alves, K.
    Wahl, J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S457 - S458
  • [28] Elimination Half-Life May Explain the Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1
    Calcagno, Andrea
    Boglione, Lucio
    De Rosa, Francesco Giuseppe
    Di Perri, Giovanni
    Bonora, Stefano
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) : 1677 - U195
  • [29] Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype I infection: an indirect comparison meta-analysis
    Cooper, Curtis L.
    Druyts, Eric
    Thorlund, Kristian
    Nachega, Jean B.
    El Khoury, Antoine C.
    O'Regan, Christopher
    Mills, Edward J.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 105 - 130
  • [30] Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis
    Hezode, Christophe
    Fontaine, Helene
    Dorival, Celine
    Zoulim, Fabien
    Larrey, Dominique
    Canva, Valerie
    De Ledinghen, Victor
    Poynard, Thierry
    Samuel, Didier
    Bourliere, Marc
    Alric, Laurent
    Raabe, Jean-Jacques
    Zarski, Jean-Pierre
    Marcellin, Patrick
    Riachi, Ghassan
    Bernard, Pierre-Henri
    Loustaud-Ratti, Veronique
    Chazouilleres, Olivier
    Abergel, Armand
    Guyader, Dominique
    Metivier, Sophie
    Tran, Albert
    Di Martino, Vincent
    Causse, Xavier
    Dao, Thong
    Lucidarme, Damien
    Portal, Isabelle
    Cacoub, Patrice
    Gournay, Jerome
    Grando-Lemaire, Veronique
    Hillon, Patrick
    Attali, Pierre
    Fontanges, Thierry
    Rosa, Isabelle
    Petrov-Sanchez, Ventzislava
    Barthe, Yoann
    Pawlotsky, Jean-Michel
    Pol, Stanislas
    Carrat, Fabrice
    Bronowicki, Jean-Pierre
    GASTROENTEROLOGY, 2014, 147 (01) : 132 - U235
12345